Microsoft word - n-065-26.doc

Sonnenschein
Lithium GmbH
Industriestrasse 22
D-63654 Büdingen
Technical Notice
Safety data sheet
1. Identification
1.1 Product Name:
1.2 Company:
1.3 Emergency Telephone Number:
2. Composition/Information on Ingredients
R 14/15 Reacts violently with water liberating extremely flammable gases Important Note: The material in this section may only represent a hazard if the integrity of
the battery is compromised, or if the battery is physically or electrically abused.
E-Mail: info@sonnenschein-lithium.de Internet: Sonnenschein
Lithium GmbH
Industriestrasse 22
D-63654 Büdingen


3. Hazards
Identification
Warning:
Fire, explosion, and severe, burn hazard. Do not recharge, disassemble, heat above 100 °C (series SL-500: 145 °C), incinerate, or expose contents to water. Protection from charging:
Whenever lithium batteries are not the single power source in a circuit the following measures recommended by Underwriters Laboratories are relevant. The cells should not be connected in series with an electrical power source that would increase the forward current through the cells. The circuit for these cells shall include one of the following: Two suitable diodes or the equivalent in series with the cells to prevent any reverse (charging) current. The second diode is used to provide protection in the event that one should fail. Quality control, or equivalent procedures, shall be established by the device manufacturer to ensure the diode polarity is correct for each unit, A blocking diode or the equivalent to prevent any reverse (charging) current and a resistor to limit current in case of a diode failure. The resistor should be sized to limit the reverse charging) current to the maximums given in the data sheets. 4. First Aid Measures
Immediately flush with plenty of water for at least 15 minutes. If symptoms are present after flushing, get medical attention. Immediately flush with plenty of water for at least 15 minutes and get medical attention. With large quantities and irritation of the respiratory tract medical surveillance for 48 hours. Immediately inhale Cortisone Spray, e.g. Pulmicort. Remove particles of lithium from skin as rapidly as possible. Immediately flush with plenty of water for at least 15 minutes and get medical attention. Immediately flush with plenty of water for at least 15 minutes and get immediate medical attention. E-Mail: info@sonnenschein-lithium.de Internet: Sonnenschein
Lithium GmbH
Industriestrasse 22
D-63654 Büdingen


5. Fire - fighting measures
• Copious amounts of cold water is an effective extinguishing medium for lithium • Lith-X (Class D extinguishing media) is effective on fires involving only a few lithium • Do not use CO2 or Halon type extinguishers. • Dry chemical type extinguishers have limited extinguishing potential • Use a positive pressure self-contained breathing apparatus if batteries are involved in a • Full protective clothing is necessary. • During water application caution is advised as burning pieces of lithium may be ejected 6. Accidental release measures
When the battery housing is damaged, small amounts of electrolyte may leak. Seal battery air tight in a plastic bag, adding some chalk (CaCO3) or lime (CaO) powder or Vermiculite. Electrolyte traces may be wiped off dryly using household paper. Rinse with water afterwards. 7. Handling and Storage
• Do not allow terminals to short-circuit. • Storage preferably in a cool (below 21 °C), dry area that is subject to little temperature • Do not place near heating equipment, nor expose to direct sunlight for long periods. Elevated temperatures can result in reduced battery service life. 8. Exposure controls / personal protection
9. Physical and chemical properties
E-Mail: info@sonnenschein-lithium.de Internet: Sonnenschein
Lithium GmbH
Industriestrasse 22
D-63654 Büdingen


10. Stability and reactivity
May rupture violently when heated above 145 °C or when charged. 11. Toxicological information
12. Ecological information
The batteries do not contain mercury, cadmium or other heavy metals. 13. Disposal Considerations
• Dispose by incineration or burial at permitted waste treatment and/or disposal sites. • Batteries do not contain hazardous materials according to EC directives 91/157/EEC and • For large quantities a disposal service is offered upon request. 14. Transport information
LITHIUM BATTERIES CONTAINED IN EQUIPMENT, or Special provisions and packing instructions: For more information see www.sonnenschein-lithium.de > site map > Transport Regulations E-Mail: info@sonnenschein-lithium.de Internet: Sonnenschein
Lithium GmbH
Industriestrasse 22
D-63654 Büdingen


15. Regulatory information
16. Other information
• Sonnenschein Lithium Batteries are registered by Underwriters Laboratories, Northbrook, - Sonnenschein Lithium Product Data Catalogue - Sonnenschein Lithium Technical Brochure. • For lithium batteries in general, Safety standard IEC 60086-4 applies. It contains detailed recommendations for manufacturers of equipment and users. • Visit our web site under www.sonnenschein-lithium.de. The information contained herein is furnished without warranty of any kind. Users should consider these data only as a supplement to other information gathered by them and must make independent determinations of the suitability and completeness of information from all sources to assure proper use and disposal of these materials and the safety and health of employees and customers. E-Mail: info@sonnenschein-lithium.de Internet:

Source: http://www.elektrotools.de/produktdownloads/103882-Batteriepack_14,4V_Li_96300.pdf

Doi:10.1016/j.parkreldis.2004.03.00

Parkinsonism and Related Disorders 10 (2004) 323–334Winona Tsea,*, Maria G. Cersosimob, Jean-Michel Graciesa, Susan Morgelloc,aDepartment of Neurology, Mount Sinai Medical Center, One Gustave L. Levy Place, Box 1052, New York, NY 10029, USAbDepartment of Neurology, University of Buenos Aires, Buenos Aires, ArgentinacDepartment of Pathology, Mount Sinai Medical Center, New York, NY, USAM

Microsoft word - documento13383

FICHA TÉCNICA 1. NOMBRE DEL MEDICAMENTO CITALOPRAM PHARMAGENUS 20 mg comprimidos recubiertos con película EFG CITALOPRAM PHARMAGENUS 30 mg comprimidos recubiertos con película EFG 2. COMPOSICIÓN CUALITATIVA Y CUANTITATIVA Cada comprimido de Citalopram Pharmagenus 20 mg contiene: Citalopram (D.O.E.) (hidrobromuro) 20 mg Excipientes: Lactosa monohidrato 80,8 mg Almidón de maíz 1

Copyright ©2018 Sedative Dosing Pdf